Imbalance between tissue inhibitor of metalloproteinase-4 and matrix metalloproteinases during acute myocardial [correction of myoctardial] ischemia-reperfusion injury
about
Matrix metalloproteinases contribute to endotoxin and interleukin-1beta induced vascular dysfunctionMatrix metalloproteinase-1 and its inhibitor, TIMP-1, in systolic heart failure: relation to functional data and prognosis.Inhibition of MMP-2 expression with siRNA increases baseline cardiomyocyte contractility and protects against simulated ischemic reperfusion injuryBronchiolitis obliterans organizing pneumonia in Swine associated with porcine circovirus type 2 infection.Proteinase and growth factor alterations revealed by gene microarray analysis of human diabetic corneasMyocardial matrix metalloproteinase-2: inside out and upside down.Targeted deletion of CC chemokine receptor 2 attenuates left ventricular remodeling after experimental myocardial infarction.Acute actions and novel targets of matrix metalloproteinases in the heart and vasculatureInterruption of endothelin signaling modifies membrane type 1 matrix metalloproteinase activity during ischemia and reperfusionTIMP-1/MMP-9 imbalance in brain edema in rats with fulminant hepatic failure.Intracellular regulation of matrix metalloproteinase-2 activity: new strategies in treatment and protection of heart subjected to oxidative stressMatrix metalloproteinase-2 and myocardial oxidative stress injury: beyond the matrix.Intracellular substrate cleavage: a novel dimension in the biochemistry, biology and pathology of matrix metalloproteinases.Tissue inhibitor of metalloproteinases (TIMPs) in heart failure.Targeting MMP-2 to treat ischemic heart injury.Peroxynitrite inactivates human-tissue inhibitor of metalloproteinase-4.Ischemia-induced cleavage of cadherins in NRK cells requires MT1-MMP (MMP-14).Ischemia-induced cleavage of cadherins in NRK cells: evidence for a role of metalloproteinases.MMP-2, MMP-9, and TIMP-4 and Response to Aspirin in Diabetic and Nondiabetic Patients with Stable Coronary Artery Disease: A Pilot Study.Near-infrared fluorescent imaging of matrix metalloproteinase activity after myocardial infarction.Mice with tissue inhibitor of metalloproteinases 4 (Timp4) deletion succumb to induced myocardial infarction but not to cardiac pressure overload.Ephrin-Eph signaling as a potential therapeutic target for the treatment of myocardial infarction.Inhibition of matrix metalloproteinases prevents peroxynitrite-induced contractile dysfunction in the isolated cardiac myocyte.Protective action of doxycycline against diabetic cardiomyopathy in rats.Heterogeneous effects of tissue inhibitors of matrix metalloproteinases on cardiac fibroblasts.In vivo protective effects of urocortin on ischemia-reperfusion injury in rat heart via free radical mechanisms.L-Carnitine Attenuates Cardiac Dysfunction by Ischemic Insults Through Akt Signaling Pathway.Apelin-induced cardioprotection against ischaemia/reperfusion injury: roles of epidermal growth factor and Src.Activation of proteolytic enzymes and depression of the sarcolemmal Na+/K+-ATPase in ischemia-reperfused heart may be mediated through oxidative stress.Plasma MMP2/TIMP4 Ratio at Follow-up Assessment Predicts Disease Progression of Idiopathic Pulmonary Arterial Hypertension.Effects of autologous stem cells on immunohistochemical patterns and gene expression of metalloproteinases and their tissue inhibitors in doxorubicin cardiomyopathy in a rabbit model.The cardioprotective effect of naringenin against ischemia-reperfusion injury through activation of ATP-sensitive potassium channel in rat.Adipose stromal vascular fraction improves cardiac function in chronic myocardial infarction through differentiation and paracrine activity.Activation of α1B-adrenoceptors contributes to intermittent hypobaric hypoxia-improved postischemic myocardial performance via inhibiting MMP-2 activation.Matrix metalloproteinase inhibition protects CyPD knockout mice independently of RISK/mPTP signalling: a parallel pathway to protection.Tissue inhibitor of matrix metalloproteinases 4 (TIMP4) in a population of young adults: Relations to cardiovascular risk markers and carotid artery intima-media thickness. The Cardiovascular Risk in Young Finns Study
P2860
Q28580182-BA09AF72-7E7F-4F6B-904F-FF93CCF6C7F1Q31121727-64093AAC-9CF1-4CF7-8C6A-541184C293C4Q34039481-59409284-5519-43A3-8FB9-822F5B865CAAQ34189088-7690A706-024F-487D-AB3A-2879BF722A02Q34598912-8EB133CB-873D-4C62-96F3-0428AE7E6405Q35032465-85C3E797-B87F-4E44-B4A4-BA30D4952E2BQ35103051-CB5A41D1-8B5A-48AF-A680-63986DF03535Q35995215-ACC8ABA9-AA3D-48D3-9AD0-FB781DF51798Q37145499-D88A913E-F1C2-4D71-9D15-2C1FED034BA9Q37184471-B3B03E88-8EFB-4F0A-AD03-356CD22F0F0CQ37456901-6CA70DE7-9E8E-4259-964A-FC55958B8200Q37573155-BF1B1C43-FB9D-4F58-9AA5-55E6D1CDF0BDQ37784801-46923B7C-9989-4401-9AF0-37E0E915712EQ37895982-6E1352B7-03DA-4273-859D-B43BA7E1270FQ38225432-AB325687-3AFB-4A5A-8B90-5B425EBFDC84Q40003217-9E005F7C-216E-4159-A394-D9DE431E3A39Q40389832-911234A8-599C-4E1E-9C3C-9DF9CEF23D75Q40446304-4D4CFE50-5B8D-4E80-9B52-8B5267523255Q41099760-A752AC7B-0DBF-414B-9A43-3990934366BFQ42226932-3AB5D4E9-7576-47E5-A197-C24E7FD06955Q42286488-606229BE-D100-415F-92C5-901DFB544BD9Q42782593-A1FE6C6D-CBB0-4C35-9A7A-39BB89A6492DQ43064761-B9AC22A1-6C79-4958-BEC0-86999213186FQ43223828-551D60C0-8A62-4FCF-BB1F-5A67C2882F19Q45223757-67C6D5FD-6F36-4DDA-8273-96DF10FCEA7DQ46622841-00F81163-F931-4966-AACD-011698F85D60Q47705867-77393D08-3B47-44C3-A4FB-22D6121FC184Q48022708-A8D34842-39C8-4525-88B6-4576FC4B6CE6Q48735973-342A527F-0DE3-4F31-8BC1-939511347B2BQ50639372-7313D4A0-70A8-4D91-8379-6F596AE26CE4Q50689194-FE686E18-1EF3-4ED5-A5C5-4E55A65C9950Q51645245-7DE4D000-6BAB-4149-8F66-FF01B15AB5A7Q53187816-DA0F8920-0148-4772-849A-9906B61D7B51Q54362092-40C9EA5A-B204-47ED-96E4-A32CB8718565Q54453200-9BA15BAB-D90B-42B9-AAC6-EE30A2E13876Q57417399-EA189D10-793F-4679-A6B2-6D65C71A81CA
P2860
Imbalance between tissue inhibitor of metalloproteinase-4 and matrix metalloproteinases during acute myocardial [correction of myoctardial] ischemia-reperfusion injury
description
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2003
@ast
im Mai 2003 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2003/05/20)
@sk
vědecký článek publikovaný v roce 2003
@cs
wetenschappelijk artikel (gepubliceerd op 2003/05/20)
@nl
наукова стаття, опублікована в травні 2003
@uk
مقالة علمية (نشرت في 20-5-2003)
@ar
name
Imbalance between tissue inhib ...... l] ischemia-reperfusion injury
@ast
Imbalance between tissue inhib ...... l] ischemia-reperfusion injury
@en
Imbalance between tissue inhib ...... l] ischemia-reperfusion injury
@nl
type
label
Imbalance between tissue inhib ...... l] ischemia-reperfusion injury
@ast
Imbalance between tissue inhib ...... l] ischemia-reperfusion injury
@en
Imbalance between tissue inhib ...... l] ischemia-reperfusion injury
@nl
prefLabel
Imbalance between tissue inhib ...... l] ischemia-reperfusion injury
@ast
Imbalance between tissue inhib ...... l] ischemia-reperfusion injury
@en
Imbalance between tissue inhib ...... l] ischemia-reperfusion injury
@nl
P2093
P1433
P1476
Imbalance between tissue inhib ...... l] ischemia-reperfusion injury
@en
P2093
Costas J. Schulze
Grzegorz Sawicki
Jolanta Sawicka
Wenjie Wang
Wilma L. Suarez-Pinzon
P304
P356
10.1161/01.CIR.0000065603.09430.58
P407
P577
2003-05-20T00:00:00Z